MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CVKD — Cadrenal Therapeutics, Inc. Common Stock
NasdaqCadrenal Therapeutics, Inc. Common Stock
$0.94
-0.03(-3.07%)
- O
- 0.98
- H
- 1.01
- L
- 0.85
- V
- 149.59K
⏱️ End-of-day dataAs of Oct 2, 2026
CVKD — Latest News & Headlines
4 StoriesCadrenal Therapeutics CEO to Present at Lytham Partners Fall 2026 Investor Conference - quiverquant.com
Cadrenal Therapeutics CEO to Present at Lytham Partners Fall 2026 Investor Conference quiverquant.com
Cadrenal Therapeutics (CVKD) Slips 4.46% to $1.07, Drifting Toward Lower Support - Systematic Flow - dars.gov.et
Cadrenal Therapeutics (CVKD) Slips 4.46% to $1.07, Drifting Toward Lower Support - Systematic Flow dars.gov.et
Cadrenal Therapeutics shareholders approve equity plan amendment and warrant issuance - Investing.com India
Cadrenal Therapeutics shareholders approve equity plan amendment and warrant issuance Investing.com India
Cadrenal Shareholders Approve Equity Plan and Board Changes - TipRanks
Cadrenal Shareholders Approve Equity Plan and Board Changes TipRanks